News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Molecular Devices, Inc. (MDCC) Introduces PatchXpress Plus With Action Potential Measurement Functionality


2/27/2012 9:14:32 AM

Sunnyvale, CA, February 27, 2012: Molecular Devices, LLC, has introduced a current-clamp upgrade kit, PatchXpress® Plus, for its PatchXpress 7000A automated patch clamp system. The kit enables analysis of cardiac and neuronal cell excitability through measurement of action potentials.

PatchXpress Plus allows ion channel safety labs to perform automated action potential prolongation assays, to test the effects of candidate ion channel drugs on action potential shape, duration or burst activity in excitable cells such as pluripotent stem-cell derived cardiomyocytes. The effects of candidate drugs can also be tested on action potential burst firing in neurons or on resting membrane potentials in excitable or non-excitable cells.

PatchXpress Commander software can be used to pass increasing amounts of current into the cell being measured, with automated detection of action potential firing. In addition, a modified version of DataXpress analysis software measures action potential durations based on user-selectable parameters.

“Recent advances in the availability of cardiac and neuronal stem-cell derived cells have led to an increased need for this enhanced capability in patch clamp systems. Molecular Devices is committed to delivering innovative products that meet scientists needs, and we’re excited to offer the upgraded PatchXpress Plus as a solution,” said Klaus Lun, Vice President of BioDiscovery at Molecular Devices.

About Molecular Devices, LLC

Molecular Devices is one of the world’s leading providers of high-performance bioanalytical measurement systems, software and consumables for life science research, pharmaceutical and biotherapeutic development. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. These leading-edge products enable scientists to improve productivity and effectiveness, ultimately accelerating research and the discovery of new therapeutics

Molecular Devices is committed to the continual development of innovative solutions for life science applications. The Company is headquartered in Silicon Valley with offices around the globe.

For more information about the complete product portfolio, visit www.moleculardevices.com

Media contacts:

Jennifer McKie

Molecular Devices

Tel: +1 (408) 747-1700

Email: Jennifer.McKie@moldev.com

Katie Odgaard

Zyme Communications

Tel: +44 7787 502 947

Email: Katie.odgaard@zymecommunications.com


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES